Soaring Eagle Acquisition Corp. (SRNG)
|Net Income (ttm)||n/a|
|Trading Day||June 22|
|Day's Range||9.89 - 9.92|
|52-Week Range||9.84 - 10.89|
BOSTON, May 24, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on...
'SPACs Attack' Recap: Looking Back At 3 SPAC Deals, SPAC Rumors And The Latest SPAC Headlines And Earnings
Last week featured three announced SPAC deals. The week also had earnings from several well-known former SPACs.
Ginkgo Bioworks isn't letting any grass grow under its feet. Just a week after inking a $2.5 billion pact to go public via the special purpose acquisition company Soaring Eagle Acquisition Corp. ( SRNG ...
Last week featured eight announced SPAC deals. The week also had earnings from several well-known former SPACs.
Ginkgo Agrees to $17.5 Billion Merger With Harry Sloan SPAC
May.11 -- Ginkgo Bioworks Inc., which calls itself an “organism design” company, has agreed to go public in a $17.5 billion merger with a blank-check firm backed by former Hollywood executive Harry Sloa...
What Investors Should Know About Ginkgo Bioworks SPAC Deal: 'Cell Programming Has The Potential To Impact Every Physi...
A well seasoned SPAC management team announced a SPAC deal Tuesday to bring a cell programming company public. The SPAC Deal: Ginkgo Bioworks is going public in a SPAC deal with Soaring Eagle Acquisitio...
Ginkgo Bioworks, a biotech company based in Boston, announced that it will go public via a merger with Soaring Eagle Acquisition Corp. (SRNG), a special purpose acquisition vehicle (SPAC), in a deal tha...
Ginkgo Bioworks on going public in $15 billion SPAC deal
CNBC's "Squawk on the Street" team discusses Ginkgo Bioworks' SPAC deal with CEO Jason Kelly.
Ginkgo Bioworks is going public via a merger with former MGM CEO Harry Sloan's SPAC in a deal that values the biotech company at $15 billion.
SRNGU stock is moving upward today as rumors swirl about an acquistion of biotech company Ginkgo Bioworks. Here's the low-down.
Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report
One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public. The SPAC Rumor: Bloomberg reports Ginkgo Bioworks...
With SPACs, you can get in on the ground floor of good -- or bad -- ideas, or you can just bet on the guys holding the checkbook. The post 8 Major Players in the SPAC Game to Watch appeared first on Inv...
Eagle Acquisition is looking for its seventh deal with SRNGU stock. The team behind it previously took DraftKings and Skillz public.
Soaring Eagle Acquisition Corp., Led by Eagle Equity Partners' Harry Sloan, Jeff Sagansky and Eli Baker Announces Pri...
NEW YORK--(BUSINESS WIRE)--Soaring Eagle Acquisition Corp., led by Harry Sloan and Founding Investor Jeff Sagansky, Announces Pricing of $1.5 Billion IPO
A blank-check acquisition company backed by investors Harry Sloan and Eli Baker has abandoned a novel plan that would have enabled it to take multiple companies public, according to regulatory filings p...
Soaring Eagle Acquisition Corp. has filed to go public with an IPO on the NASDAQ.
Soaring Eagle Acquisition is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to capitalize on the ability of our management team to identify and combine with a business or businesses that can benefit from our management team’s established global relationships and operating experience. Our management team has extensive experience in identifying and executing strategic investments glo... [Read more...]
|IPO Date |
Feb 24, 2021
Harry E. Sloan
|Stock Exchange |
|Ticker Symbol |